ORIENTBIO, Inc.(KR:002630)
₩1,277.00+4.00 (+0.31%)
KR:002630
ORIENTBIO, Inc. financials statements
₩1,277.00
At close:+4.00 (+0.31%)
Want to see KR:002630 full AI Analyst Report?
ORIENTBIO, Inc. (002630) Income Statement
ORIENTBIO, Inc. Income Statement
Last quarter (Q1 2026), ORIENTBIO, Inc.'s total revenue was ₩6.59B, a decrease of 14.19% from the same quarter last year. In Q1, ORIENTBIO, Inc.'s net income was ₩4.85B. See ORIENTBIO, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₩ 29.75B | ₩ 29.40B | ₩ 28.01B | ₩ 28.82B | ₩ 26.28B | |
| ₩ 3.96B | ₩ 7.20B | ₩ 9.58B | ₩ 9.82B | ₩ 9.01B | |
| ₩ 8.40B | ₩ 10.27B | ₩ 10.23B | ₩ 8.37B | ₩ 12.79B | |
| Depreciation and Amortization | ₩ 2.20B | ₩ 1.95B | ₩ 2.68B | ₩ 3.09B | ₩ 3.93B |
| ₩ -2.24B | ₩ -11.02B | ₩ 15.67B | ₩ -9.25B | ₩ 997.25M | |
| ₩ -4.44B | ₩ -3.08B | ₩ -645.95M | ₩ 1.45B | ₩ -3.78B | |
| ₩ -125.19M | ₩ -10.12B | ₩ 13.52B | ₩ -14.04B | ₩ 419.55M | |
| ₩ -4.57B | ₩ -13.19B | ₩ 12.87B | ₩ -12.59B | ₩ -3.36B | |
| ₩ -4.57B | ₩ -13.19B | ₩ 12.87B | ₩ -12.42B | ₩ 34.20B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -154.06 | ₩ -445.14 | ₩ 434.22 | ₩ -419.12 | ₩ -52.58 |
| Diluted EPS | ₩ -154.06 | ₩ -445.14 | ₩ 434.22 | ₩ -419.12 | ₩ -52.58 |
| Weighted Average Shares Outstanding | 29.64M | 29.64M | 29.64M | 29.64M | 29.65M |
| Weighted Average Shares Outstanding (Diluted) | 29.64M | 29.64M | 29.64M | 29.64M | 29.65M |
Currency in KRW

